Physician profile
Gregory Turowski
NPI 1831274190
$14,512.08
in general payments reported to CMS, 2019-2025
12 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $317 · 2021: $1,315 · 2022: $692 · 2023: $103 · 2024: $297 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11,132.37 | 2019-2022 | |
| Merz North America, INC. | $2,254.98 | 2019-2022 | |
| Abbvie INC. | $290.55 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Bard Peripheral Vascular, INC. | $283.17 | 2021 | |
| Motiva USA, LLC | $210.79 | 2024-2025 | |
| Davol INC. | $126.29 | 2022 | |
| Galderma Laboratories, L.P. | $80.81 | 2021-2023 | |
| Mentor Worldwide LLC | $54.78 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Solta Medical, A Division of Bausch Health US, LLC | $24.87 | 2022 | |
| Sientra, INC. | $22.86 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.90 | 2025 | Exparel |
| Mesh Suture INC | $13.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Turowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.